As per this study, the Global Osteoarthritis Drug Market was valued USD XX MN (by revenue) in 2021 and is anticipated to reach USD XX MN by 2028 with a CAGR of XX%.
Osteoarthritis is the type of arthritis; characterized by joint inflammation, joint pain, swelling and stiffness. It is the medical condition, which results from break down of joint cartilage. The osteoarthritis can be treated by life style changes, physical measures, medications, therapies, surgeries or joint replacement.
Market Dynamics
The market is gaining high demand on the account of the rapid increase in the count of the patients suffering from osteoarthritis. The increasing aged population and increase in prevalence of bone diseases and obesity is driving the market growth. The rise in R&D activities, availability of innovative & advanced treatments is further contributing the market growth. On the flip side, the high cost of treatment is likely to hinder the growth of this market.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of osteoarthritis drug.
Market Segmentation
The broad osteoarthritis drug market has been sub-grouped into drug class, route of administration and distribution channel. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Drug Class
- Corticosteroids
- NSAIDS
- Viscosupplementation Agents
- Others
By Route Of Administration
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Analysis
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for osteoarthritis drug in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Global Osteoarthritis Drug Market Share by Region (Representative Graph)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the osteoarthritis drug market include Alkem Laboratories, Anika Therapeutics, Inc., Bioventus, Inc., Chugai Pharmaceutical Co., Limited, Ferring B.V., Horizon Pharma plc, Pfizer Inc., Sanofi, Flexion Therapeutics, Inc. and Zimmer Biomet Holdings, Inc. among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Osteoarthritis Drug Market
2.2. Global Osteoarthritis Drug Market Snapshot
3 . OSTEOARTHRITIS DRUG – INDUSTRY ANALYSIS
3.1. Introduction
3.2. Market Drivers of Osteoarthritis Drug Market
3.3. Market Restraints of Osteoarthritis Drug Market
3.4. Opportunities of Osteoarthritis Drug Market
3.5. Trends of Osteoarthritis Drug Market
3.6. Porter’s Five Force Analysis of Osteoarthritis Drug Market
3.7. Osteoarthritis Drug Market Attractiveness Analysis
3.7.1 Market Attractive Analysis by Drug Class
3.7.2 Market Attractive Analysis by Route Of Administration
3.7.3 Market Attractive Analysis by By Distribution Channel
3.7.4 Market Attractive Analysis by Region
4 . VALUE CHAIN ANALYSIS
4.1. Osteoarthritis Drug Value Chain Analysis
4.2. Osteoarthritis Drug Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Osteoarthritis Drug Raw Material Manufactures List
4.2.3. Price Trend of Osteoarthritis Drug Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL OSTEOARTHRITIS DRUG MARKET ANALYSIS BY DRUG CLASS
5.1 Overview by Drug Class
5.2 Global Osteoarthritis Drug Market Analysis by Drug Class
5.3 Market Analysis of Corticosteroids by Regions
5.4 Market Analysis of NSAIDS by Regions
5.5 Market Analysis of Viscosupplementation Agents by Regions
5.6 Market Analysis of Others by Regions
6 . GLOBAL OSTEOARTHRITIS DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
6.1 Overview by Route Of Administration
6.2 Global Osteoarthritis Drug Market Analysis by Route Of Administration
6.3 Market Analysis of Oral by Regions
6.4 Market Analysis of Parenteral by Regions
6.5 Market Analysis of Topical by Regions
7 . GLOBAL OSTEOARTHRITIS DRUG MARKET ANALYSIS BY BY DISTRIBUTION CHANNEL
7.1 Overview by By Distribution Channel
7.2 Global Osteoarthritis Drug Market Analysis by By Distribution Channel
7.3 Market Analysis of Hospital Pharmacies by Regions
7.4 Market Analysis of Retail Pharmacies by Regions
7.5 Market Analysis of Online Pharmacies by Regions
8 . GLOBAL OSTEOARTHRITIS DRUG MARKET ANALYSIS BY GEOGRAPHY
8.1. Regional Outlook
8.2. Introduction
8.3. North America
8.3.1. Overview
8.3.2. North America Osteoarthritis Drug Market Estimate by Country
8.3.3. United State
8.3.4. Rest of North America
8.4. Europe
8.4.1. Overview
8.4.2. Europe Osteoarthritis Drug Market Estimate by Market Segment
8.4.3. Europe Osteoarthritis Drug Market Estimate by Country
8.4.4. United Kingdom
8.4.5. France
8.4.6. Germany
8.4.7 Rest of Europe
8.5. Asia Pacific
8.5.1. Overview
8.5.2. Asia Pacific Osteoarthritis Drug Market Estimate by Market Segment
8.5.3. Asia Pacific Osteoarthritis Drug Market Estimate by Country
8.5.4. China
8.5.5. Japan
8.5.6. India
8.5.7. Rest of Asia Pacific
8.6. Latin America
8.6.1. Overview
8.6.2. Latin America Osteoarthritis Drug Market Estimate by Market Segment
8.6.3. Latin America Osteoarthritis Drug Market Estimate by Country
8.6.4. Brazil
8.6.5. Rest of Latin America
8.7. Middle East & Africa
8.7.1. Overview
8.7.2. Middle East & Africa Osteoarthritis Drug Market Estimate by Market Segment
8.7.3. Middle East & Africa Osteoarthritis Drug Market Estimate by Country
8.7.4. Middle East
8.7.5. Africa
9 . COMPETITIVE LANDSCAPE OF THE OSTEOARTHRITIS DRUG COMPANIES
9.1. Osteoarthritis Drug Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments
10 . COMPANY PROFILES OF OSTEOARTHRITIS DRUG INDUSTRY
10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Alkem Laboratories
10.3.1. Company Overview
10.3.2. Financials
10.3.3. Products
10.3.4. Recent Developments
10.4. Anika Therapeutics, Inc.
10.4.1. Company Overview
10.4.2. Financials
10.4.3. Products
10.4.4. Recent Developments
10.5. Bioventus, Inc.
10.5.1. Company Overview
10.5.2. Financials
10.5.3. Products
10.5.4. Recent Developments
10.6. Chugai Pharmaceutical Co., Limited
10.6.1. Company Overview
10.6.2. Financials
10.6.3. Products
10.6.4. Recent Developments
10.7. Ferring B.V.
10.7.1. Company Overview
10.7.2. Financials
10.7.3. Products
10.7.4. Recent Developments
10.8. Horizon Pharma plc.
10.8.1. Company Overview
10.8.2. Financials
10.8.3. Products
10.8.4. Recent Developments
10.9. Pfizer Inc.
10.9.1. Company Overview
10.9.2. Financials
10.9.3. Products
10.9.4. Recent Developments
10.10. Sanofi, Flexion Therapeutics, Inc.
10.10.1. Company Overview
10.10.2. Financials
10.10.3. Products
10.10.4. Recent Developments
10.11. Zimmer Biomet Holdings, Inc.
10.11.1. Company Overview
10.11.2. Financials
10.11.3. Products
10.11.4. Recent Developments
11. IMPACT ANALYSIS OF COVID-19 OUTBREAK
11.1. Impact Analysis of Covid-19 Outbreak on Osteoarthritis Drug Market
11.1.1. Direct Impact on Production
11.1.2. Supply Chain and Market Disruption
11.1.3. Financial Impact on Firms and Financial Markets
11.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
11.3. Osteoarthritis Drug Market: Pre V/S Post COVID-19 Market
11.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Osteoarthritis Drug Market Size in 2020, by Scenario
11.5. COVID-19: Micro and Macro Factor Analysis on Osteoarthritis Drug Market
*Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Global Osteoarthritis Drug Market Snapshot
- Drivers of The Global Osteoarthritis Drug Market Impact Analysis
- Restraints of The Global Osteoarthritis Drug Market Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- COVID-19 Impact Analysis by Production, Import, Export and Demand
- Pre V/S Post COVID-19 Market
- Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Market Size In 2020, By Scenario
- COVID-19: Micro and Macro Factor Analysis on the Market
- Global Osteoarthritis Drug Market Analysis by Drug Class (USD MN)
- Global Osteoarthritis Drug Market Analysis in Corticosteroids by Geography (USD MN)
- Global Osteoarthritis Drug Market Analysis in NSAIDS by Geography (USD MN)
- Global Osteoarthritis Drug Market Analysis in Viscosupplementation Agents by Geography (USD MN)
- Global Osteoarthritis Drug Market Analysis in Others by Geography (USD MN)
- Global Osteoarthritis Drug Market Analysis by Route Of Administration (USD MN)
- Global Osteoarthritis Drug Market Analysis in Oral by Geography (USD MN)
- Global Osteoarthritis Drug Market Analysis in Parenteral by Geography (USD MN)
- Global Osteoarthritis Drug Market Analysis in Topical by Geography (USD MN)
- Global Osteoarthritis Drug Market Analysis by By Distribution Channel (USD MN)
- Global Osteoarthritis Drug Market Analysis in Hospital Pharmacies by Geography (USD MN)
- Global Osteoarthritis Drug Market Analysis in Retail Pharmacies by Geography (USD MN)
- Global Osteoarthritis Drug Market Analysis in Online Pharmacies by Geography (USD MN)
- Global Osteoarthritis Drug Market by Geography (USD MN)
- North America Osteoarthritis Drug Market Analysis by Drug Class (USD MN)
- North America Osteoarthritis Drug Market Estimate by Route Of Administration (USD MN)
- North America Osteoarthritis Drug Market Estimate by By Distribution Channel (USD MN)
- North America Osteoarthritis Drug Market Estimate by Country (USD MN)
- United State Osteoarthritis Drug Market Analysis by Drug Class (USD MN)
- United State Osteoarthritis Drug Market Estimate by Route Of Administration (USD MN)
- United State Osteoarthritis Drug Market Analysis by By Distribution Channel (USD MN)
- Rest of North America Osteoarthritis Drug Market Analysis by Drug Class (USD MN)
- Rest of North America Osteoarthritis Drug Market Estimate by Route Of Administration (USD MN)
- Rest of North America Osteoarthritis Drug Market Estimate by By Distribution Channel(USD MN)
- Europe Osteoarthritis Drug Market Analysis by Drug Class (USD MN)
- Europe Osteoarthritis Drug Market Estimate by Route Of Administration (USD MN)
- Europe Osteoarthritis Drug Market Estimate by By Distribution Channel (USD MN)
- Europe Osteoarthritis Drug Market Estimate by 38 (USD MN)
- United Kingdom Osteoarthritis Drug Market Analysis by Drug Class (USD MN)
- United Kingdom Osteoarthritis Drug Market Estimate by Route Of Administration (USD MN)
- United Kingdom Osteoarthritis Drug Market Estimate by By Distribution Channel (USD MN)
- France Osteoarthritis Drug Market Analysis by Drug Class (USD MN)
- France Osteoarthritis Drug Market Estimate by Route Of Administration (USD MN)
- France Osteoarthritis Drug Market Estimate by By Distribution Channel (USD MN)
- Germany Osteoarthritis Drug Market Analysis by Drug Class (USD MN)
- Germany Osteoarthritis Drug Market Estimate by Route Of Administration (USD MN)
- Germany Osteoarthritis Drug Market Estimate by By Distribution Channel (USD MN)
- Rest of Europe Osteoarthritis Drug Market Analysis by Drug Class (USD MN)
- Rest of Europe Osteoarthritis Drug Market Estimate by Route Of Administration (USD MN)
- Rest of Europe Osteoarthritis Drug Market Estimate by By Distribution Channel (USD MN)
- Asia Pacific Osteoarthritis Drug Market Analysis by Drug Class (USD MN)
- Asia Pacific Osteoarthritis Drug Market Estimate by Route Of Administration (USD MN)
- Asia Pacific Osteoarthritis Drug Market Estimate by By Distribution Channel (USD MN)
- Asia Pacific Osteoarthritis Drug Market Estimate by Country (USD MN)
- China Osteoarthritis Drug Market Analysis by Drug Class (USD MN)
- China Osteoarthritis Drug Market Estimate by Route Of Administration (USD MN)
- China Osteoarthritis Drug Market Estimate by By Distribution Channel (USD MN)
- Japan Osteoarthritis Drug Market Analysis by Drug Class (USD MN)
- Japan Osteoarthritis Drug Market Estimate by Route Of Administration (USD MN)
- Japan Osteoarthritis Drug Market Estimate by By Distribution Channel (USD MN)
- India Osteoarthritis Drug Market Analysis by Drug Class (USD MN)
- India Osteoarthritis Drug Market Estimate by Route Of Administration (USD MN)
- India Osteoarthritis Drug Market Estimate by By Distribution Channel (USD MN)
- Rest of Asia Pacific Osteoarthritis Drug Market Analysis by Drug Class (USD MN)
- Rest of Asia Pacific Osteoarthritis Drug Market Estimate by Route Of Administration (USD MN)
- Rest of Asia Pacific Osteoarthritis Drug Market Estimate by By Distribution Channel (USD MN)
- Latin America Osteoarthritis Drug Market Analysis by Drug Class (USD MN)
- Latin America Osteoarthritis Drug Market Estimate by Route Of Administration (USD MN)
- Latin America Osteoarthritis Drug Market Estimate by By Distribution Channel (USD MN)
- Latin America Osteoarthritis Drug Market Estimate by Country (USD MN)
- Brazil Osteoarthritis Drug Market Analysis by Drug Class (USD MN)
- Brazil Osteoarthritis Drug Market Estimate by Route Of Administration (USD MN)
- Brazil Osteoarthritis Drug Market Estimate by By Distribution Channel (USD MN)
- Rest of Latin America Osteoarthritis Drug Market Analysis by Drug Class (USD MN)
- Rest of Latin America Osteoarthritis Drug Market Estimate by Route Of Administration (USD MN)
- Rest of Latin America Osteoarthritis Drug Market Estimate by By Distribution Channel (USD MN)
- Middle East & Africa Osteoarthritis Drug Market Analysis by Drug Class (USD MN)
- Middle East & Africa Osteoarthritis Drug Market Estimate by Route Of Administration (USD MN)
- Middle East & Africa Osteoarthritis Drug Market Estimate by By Distribution Channel (USD MN)
- Middle East & Africa Osteoarthritis Drug Market Estimate by Country (USD MN)
- Middle East Osteoarthritis Drug Market Analysis by Drug Class (USD MN)
- Middle East Osteoarthritis Drug Market Estimate by Route Of Administration (USD MN)
- Middle East Osteoarthritis Drug Market Estimate by By Distribution Channel (USD MN)
- Africa Osteoarthritis Drug Market Analysis by Drug Class (USD MN)
- Africa Osteoarthritis Drug Market Estimate by Route Of Administration (USD MN)
- Africa Osteoarthritis Drug Market Estimate by By Distribution Channel (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisiton
- New Product Launch
- Other Developments
- Company Market Share Analysis
LIST OF FIGURES
- Research Scope of Osteoarthritis Drug Report
- Market Research Process
- Market Research Methodology
- Global Osteoarthritis Drug Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Drug Class
- Market Attractiveness Analysis by Route Of Administration
- Market Attractiveness Analysis by By Distribution Channel
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Osteoarthritis Drug Market Analysis by Drug Class (USD MN)
- Global Osteoarthritis Drug Market Analysis in Corticosteroids by Geography (USD MN)
- Global Osteoarthritis Drug Market Analysis in NSAIDS by Geography (USD MN)
- Global Osteoarthritis Drug Market Analysis in Viscosupplementation Agents by Geography (USD MN)
- Global Osteoarthritis Drug Market Analysis in Others by Geography (USD MN)
- Global Osteoarthritis Drug Market Analysis by Route Of Administration (USD MN)
- Global Osteoarthritis Drug Market Analysis in Oral by Geography (USD MN)
- Global Osteoarthritis Drug Market Analysis in Parenteral by Geography (USD MN)
- Global Osteoarthritis Drug Market Analysis in Topical by Geography (USD MN)
- Global Osteoarthritis Drug Market Analysis by By Distribution Channel (USD MN)
- Global Osteoarthritis Drug Market Analysis in Hospital Pharmacies by Geography (USD MN)
- Global Osteoarthritis Drug Market Analysis in Retail Pharmacies by Geography (USD MN)
- Global Osteoarthritis Drug Market Analysis in Online Pharmacies by Geography (USD MN)
- Latin America Osteoarthritis Drug Market by Revenue
- Middle East & Africa Osteoarthritis Drug Market by Revenue
- Recent Development in Osteoarthritis Drug Industry
- Company Market Share Analysis
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.